Sandoz Group (OTCMKTS:SDZNY) Sees Strong Trading Volume – Here’s Why

Sandoz Group AG Sponsored ADR (OTCMKTS:SDZNY) shares saw strong trading volume on Tuesday . 90,759 shares changed hands during mid-day trading, an increase of 240% from the previous session’s volume of 26,684 shares.The stock last traded at $86.64 and had previously closed at $85.73.

Analyst Ratings Changes

Separately, Jefferies Financial Group upgraded Sandoz Group from a “hold” rating to a “strong-buy” rating in a research report on Thursday, February 12th. Two equities research analysts have rated the stock with a Strong Buy rating, Based on data from MarketBeat.com, the stock presently has a consensus rating of “Strong Buy”.

Sandoz Group Stock Up 0.8%

The business has a 50 day simple moving average of $77.54 and a 200-day simple moving average of $68.28. The company has a quick ratio of 0.82, a current ratio of 1.29 and a debt-to-equity ratio of 0.62.

Sandoz Group Company Profile

Sandoz Group (OTCMKTS:SDZNY) is a multinational pharmaceutical company focused on the development, manufacturing and commercialization of generic medicines and biosimilars. The company supplies off-patent small-molecule drugs as well as biologic alternatives intended to offer lower-cost therapeutic options across a range of clinical areas. Sandoz emphasizes access and affordability, positioning its portfolio to serve hospitals, pharmacies and health systems looking to expand patient access to essential therapies.

The company’s product offerings span conventional generics, complex and specialty generics, and a growing pipeline of biosimilar medicines.